search
Back to results

Ketamine for Acute Pain Management After Trauma (KAPT)

Primary Purpose

Trauma Injury, Pain, Opioid Use

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Ketamine plus usual care
Usual Care
Sponsored by
The University of Texas Health Science Center, Houston
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Trauma Injury focused on measuring Multimodal Pain Therapy, Ketamine, Trauma

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult trauma patients
  • Admission to Shock Trauma ICU (STICU) or Surgical Intermediate Unit (SIMU)
  • Randomization within 6 hours of arrival

Exclusion Criteria:

  • Patient not expected to survive
  • Contraindications to ketamine Allergy, Poorly controlled hypertension, Cardiac arrhythmia disorders (including atrial fibrillation), congestive heart failure, unstable coronary artery disease or recent myocardial infarction( MI)(within 6 months), cirrhosis, seizure disorder, and for those patients with unknown medical history - median sternotomy scar, mechanism of injury is fall from standing, 65 years of age or older, any arrhythmia on EKD)
  • pregnancy
  • in police custody
  • history of dementia or movement disorder (i.e. Parkinson's)

Sites / Locations

  • The University of Texas Health Science Center at Houston

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Ketamine plus Usual care

Usual care

Arm Description

Outcomes

Primary Outcome Measures

Average Daily Opioid Use as Measured by the Morphine Milligram Equivalents (MME) Per Day

Secondary Outcome Measures

Pain as Assessed by Score on the Numeric Rating Scale (NRS)
The NRS ranges from 0 (no pain) to 10 (worst pain), with a higher score indicating a worse outcome. This scale is used in verbal participants.
Number of Patients That Showed Signs of Delirium During In-hospital Stay
Incidence of delirium during in-hospital stay
Number of Patients That Required Unplanned Intubation During In-hospital Stay
incidence of need for unplanned intubation during in-hospital stay
Number of Patients Who Required Unplanned Admission to Intensive Care Unit During In-hospital Stay
Incidence of need for unplanned admission to an ICU
Initiation of Ketamine Drip
Time from admission to time Ketamine drip started
Duration of Ketamine Drip
Length of time Ketamine drip was infused
Number of Patients Requesting to Discontinue Ketamine
Number of patients requesting to stop Ketamine for any complaint
Use of Other Pain Control Adjuncts Including Regional Anesthesia and Lidocaine Patch
Incidence of use of additional pain control adjuncts such as regional anesthesia and lidocaine patch during hospitalization
Ventilator Free Days
Number of inpatient hospital days patients did not require mechanical ventilation
ICU Free Days
Number of inpatient hospital days patients did not require ICU level of care
Hospital Free Days
Number of days patients were not in the hospital during the first 30 days after admission
Number of Patients Discharged From the Hospital With an Opioid Prescription
Number of patients discharged from the hospital with an opioid prescription
Number of Patients Who Reported Continued Pain Continued Post-traumatic Pain at 6 Months Post Admission
Number of patients who reported continued pain at 6 months following trauma injury
Number of Patients Who Continue to Use Opioids at 6 Months Post Admission
Number of patients who continue to use opioids
Post Traumatic Stress Disorder (PTSD) as Assessed by the PC-PTSD-5 Questionnaire
The PC-PTSD-5 questionnaire asks the below 5 questions, and data are reported categorically as the number of participants who responded "yes" to each of the 5 questions. An answer of "yes" is indicative of a PTSD symptom, which is a worse outcome. In the past month, have you had nightmares about the events or thought about the events when you did not want to? In the past month, have you tried hard not to think about the events or went out of your way to avoid situations that reminded you of the events? In the past month, have you been constantly on guard, watchful, or easily startled? In the past month, have you felt numb or detached from people, activities, or your surroundings? In the past month, have you felt guilty or unable to stop blaming yourself or others for the events or any problems the events may have caused?
Risk of Future Opioid Abuse as Assessed by the Opioid Risk Tool (ORT)
Total ORT score ranges from 0 to 26. A score of 3 or lower indicates low risk for future opioid abuse, a score of 4 to 7 indicates moderate risk for opioid abuse, and a score of 8 or higher indicates a high risk for opioid abuse.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Mobility)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Self-Care)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of self-care by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Usual Activities)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their ability to carry out usual activities by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Pain/Discomfort)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of pain/discomfort by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Anxiety/Depression)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of anxiety/depression by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Current Health)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "How would you rate your health today?," and they respond with a score from 0 - 100, with a higher score indicating a better outcome.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Previous Experience)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "Have you ever experience this kind of event?," and data are reported as the number of participants who responded "yes."
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Mobility)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Self-Care)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Usual Activities)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their ability to carry out usual activities by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Pain/Discomfort)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of pain/discomfort by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Anxiety/Depression)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of anxiety/depression by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Current Health)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "How would you rate your health today?," and they respond with a score from 0 - 100, with a higher score indicating a better outcome.
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Previous Experience)
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "Have you ever experience this kind of event?," and data are reported as the number of participants who responded "yes."
Post Traumatic Stress Disorder (PTSD) as Assessed by the PC-PTSD-5 Questionnaire
The PC-PTSD-5 questionnaire asks the below 5 questions, and data are reported categorically as the number of participants who responded "yes" to each of the 5 questions. An answer of "yes" is indicative of a PTSD symptom, which is a worse outcome. In the past month, have you had nightmares about the events or thought about the events when you did not want to? In the past month, have you tried hard not to think about the events or went out of your way to avoid situations that reminded you of the events? In the past month, have you been constantly on guard, watchful, or easily startled? In the past month, have you felt numb or detached from people, activities, or your surroundings? In the past month, have you felt guilty or unable to stop blaming yourself or others for the events or any problems the events may have caused?
Pain as Assessed by Score on the Behavioral Pain Scale (BPS)
BPS score ranges from 3-12, with higher scores indicating worse pain. This assessment is used in non-verbal participants.
Pain as Assessed by Average Score on the Defense and Veterans Pain Rating Scale (DVPRS)
DVPRS scores were collected daily. For each participant, an average of the daily scores on the Defense and Veterans Pain Rating Scale was calculated. DVPRS scores range from 0 (no pain) to 10 (as bad as it could be, nothing else matters), with a higher score indicating a worse outcome.

Full Information

First Posted
October 10, 2019
Last Updated
March 30, 2023
Sponsor
The University of Texas Health Science Center, Houston
search

1. Study Identification

Unique Protocol Identification Number
NCT04129086
Brief Title
Ketamine for Acute Pain Management After Trauma
Acronym
KAPT
Official Title
Ketamine for Acute Pain After Trauma: KAPT Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
March 30, 2022 (Actual)
Study Completion Date
September 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Texas Health Science Center, Houston

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare the effectiveness of Ketamine drip along with usual care and usual care alone on trauma patients and to longitudinally quantify the pain experience of patients during hospitalization.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Trauma Injury, Pain, Opioid Use
Keywords
Multimodal Pain Therapy, Ketamine, Trauma

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
305 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ketamine plus Usual care
Arm Type
Experimental
Arm Title
Usual care
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Ketamine plus usual care
Intervention Description
Bolus of .35 mg/kg Infusion start @ 0.15 mg/kg/hr; titrate range is 0.1 - 0.25 mg/kg/hr for 24 to 48 hours after admission and each subsequent major surgery plus multi-modal pain therapy considered as standard of care. Standard of care medications include Acetaminophen 1000 mg po q6 hours, Naproxen 500 mg po q12 hours, Gabapentin 300 mg po q8 hours and Lidocaine patch q 12 hours.
Intervention Type
Drug
Intervention Name(s)
Usual Care
Intervention Description
Standard of care medications include Acetaminophen 1000 mg po q6 hours, Naproxen 500 mg po q12 hours, Gabapentin 300 mg po q8 hours and Lidocaine patch q 12 hours.
Primary Outcome Measure Information:
Title
Average Daily Opioid Use as Measured by the Morphine Milligram Equivalents (MME) Per Day
Time Frame
In-hospital days (up to 6 weeks post hospital admission)
Secondary Outcome Measure Information:
Title
Pain as Assessed by Score on the Numeric Rating Scale (NRS)
Description
The NRS ranges from 0 (no pain) to 10 (worst pain), with a higher score indicating a worse outcome. This scale is used in verbal participants.
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Number of Patients That Showed Signs of Delirium During In-hospital Stay
Description
Incidence of delirium during in-hospital stay
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Number of Patients That Required Unplanned Intubation During In-hospital Stay
Description
incidence of need for unplanned intubation during in-hospital stay
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Number of Patients Who Required Unplanned Admission to Intensive Care Unit During In-hospital Stay
Description
Incidence of need for unplanned admission to an ICU
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Initiation of Ketamine Drip
Description
Time from admission to time Ketamine drip started
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Duration of Ketamine Drip
Description
Length of time Ketamine drip was infused
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Number of Patients Requesting to Discontinue Ketamine
Description
Number of patients requesting to stop Ketamine for any complaint
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Use of Other Pain Control Adjuncts Including Regional Anesthesia and Lidocaine Patch
Description
Incidence of use of additional pain control adjuncts such as regional anesthesia and lidocaine patch during hospitalization
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Ventilator Free Days
Description
Number of inpatient hospital days patients did not require mechanical ventilation
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
ICU Free Days
Description
Number of inpatient hospital days patients did not require ICU level of care
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Hospital Free Days
Description
Number of days patients were not in the hospital during the first 30 days after admission
Time Frame
30 days post admission
Title
Number of Patients Discharged From the Hospital With an Opioid Prescription
Description
Number of patients discharged from the hospital with an opioid prescription
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Number of Patients Who Reported Continued Pain Continued Post-traumatic Pain at 6 Months Post Admission
Description
Number of patients who reported continued pain at 6 months following trauma injury
Time Frame
6 months post admission
Title
Number of Patients Who Continue to Use Opioids at 6 Months Post Admission
Description
Number of patients who continue to use opioids
Time Frame
6 months post admission
Title
Post Traumatic Stress Disorder (PTSD) as Assessed by the PC-PTSD-5 Questionnaire
Description
The PC-PTSD-5 questionnaire asks the below 5 questions, and data are reported categorically as the number of participants who responded "yes" to each of the 5 questions. An answer of "yes" is indicative of a PTSD symptom, which is a worse outcome. In the past month, have you had nightmares about the events or thought about the events when you did not want to? In the past month, have you tried hard not to think about the events or went out of your way to avoid situations that reminded you of the events? In the past month, have you been constantly on guard, watchful, or easily startled? In the past month, have you felt numb or detached from people, activities, or your surroundings? In the past month, have you felt guilty or unable to stop blaming yourself or others for the events or any problems the events may have caused?
Time Frame
6 months post admission
Title
Risk of Future Opioid Abuse as Assessed by the Opioid Risk Tool (ORT)
Description
Total ORT score ranges from 0 to 26. A score of 3 or lower indicates low risk for future opioid abuse, a score of 4 to 7 indicates moderate risk for opioid abuse, and a score of 8 or higher indicates a high risk for opioid abuse.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Mobility)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Self-Care)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of self-care by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Usual Activities)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their ability to carry out usual activities by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Pain/Discomfort)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of pain/discomfort by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Anxiety/Depression)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of anxiety/depression by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Current Health)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "How would you rate your health today?," and they respond with a score from 0 - 100, with a higher score indicating a better outcome.
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Previous Experience)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "Have you ever experience this kind of event?," and data are reported as the number of participants who responded "yes."
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Mobility)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Self-Care)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of mobility by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Usual Activities)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their ability to carry out usual activities by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Pain/Discomfort)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of pain/discomfort by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Anxiety/Depression)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked to indicate their level of anxiety/depression by choosing a predefined category, and the data for this outcome are reported categorically as the number of participants who chose each category.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Current Health)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "How would you rate your health today?," and they respond with a score from 0 - 100, with a higher score indicating a better outcome.
Time Frame
6 months post admission
Title
Health Status as Assessed by the Euro-QOL EQ-5D-3L Questionnaire (Previous Experience)
Description
For this item of the Euro-QOL EQ-5D-3L questionnaire, participants are asked the question "Have you ever experience this kind of event?," and data are reported as the number of participants who responded "yes."
Time Frame
6 months post admission
Title
Post Traumatic Stress Disorder (PTSD) as Assessed by the PC-PTSD-5 Questionnaire
Description
The PC-PTSD-5 questionnaire asks the below 5 questions, and data are reported categorically as the number of participants who responded "yes" to each of the 5 questions. An answer of "yes" is indicative of a PTSD symptom, which is a worse outcome. In the past month, have you had nightmares about the events or thought about the events when you did not want to? In the past month, have you tried hard not to think about the events or went out of your way to avoid situations that reminded you of the events? In the past month, have you been constantly on guard, watchful, or easily startled? In the past month, have you felt numb or detached from people, activities, or your surroundings? In the past month, have you felt guilty or unable to stop blaming yourself or others for the events or any problems the events may have caused?
Time Frame
Hospital discharge (about 1 to 6 weeks after admission)
Title
Pain as Assessed by Score on the Behavioral Pain Scale (BPS)
Description
BPS score ranges from 3-12, with higher scores indicating worse pain. This assessment is used in non-verbal participants.
Time Frame
Hospital discharge (up to 6 weeks post hospital admission)
Title
Pain as Assessed by Average Score on the Defense and Veterans Pain Rating Scale (DVPRS)
Description
DVPRS scores were collected daily. For each participant, an average of the daily scores on the Defense and Veterans Pain Rating Scale was calculated. DVPRS scores range from 0 (no pain) to 10 (as bad as it could be, nothing else matters), with a higher score indicating a worse outcome.
Time Frame
From time of admission to time of discharge from hospital (about 1 to 6 weeks after admission)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult trauma patients Admission to Shock Trauma ICU (STICU) or Surgical Intermediate Unit (SIMU) Randomization within 6 hours of arrival Exclusion Criteria: Patient not expected to survive Contraindications to ketamine Allergy, Poorly controlled hypertension, Cardiac arrhythmia disorders (including atrial fibrillation), congestive heart failure, unstable coronary artery disease or recent myocardial infarction( MI)(within 6 months), cirrhosis, seizure disorder, and for those patients with unknown medical history - median sternotomy scar, mechanism of injury is fall from standing, 65 years of age or older, any arrhythmia on EKD) pregnancy in police custody history of dementia or movement disorder (i.e. Parkinson's)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John P Harvin, MD
Organizational Affiliation
The University of Texas Health Science Center, Houston
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Texas Health Science Center at Houston
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35897081
Citation
Puzio TJ, Klugh J, Wandling MW, Green C, Balogh J, Prater SJ, Stephens CT, Sergot PB, Wade CE, Kao LS, Harvin JA. Ketamine for acute pain after trauma: the KAPT randomized controlled trial. Trials. 2022 Jul 27;23(1):599. doi: 10.1186/s13063-022-06511-6.
Results Reference
derived

Learn more about this trial

Ketamine for Acute Pain Management After Trauma

We'll reach out to this number within 24 hrs